Equities

Fukuda Denshi Co Ltd

Fukuda Denshi Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)7,580.00
  • Today's Change120.00 / 1.61%
  • Shares traded11.40k
  • 1 Year change+24.47%
  • Beta0.2055
Data delayed at least 20 minutes, as of Nov 15 2024 05:47 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Fukuda Denshi Co Ltd grew revenues 4.21% from 134.65bn to 140.32bn while net income improved 8.18% from 17.28bn to 18.69bn.
Gross margin51.57%
Net profit margin12.01%
Operating margin16.72%
Return on assets7.98%
Return on equity9.66%
Return on investment9.34%
More ▼

Cash flow in JPYView more

In 2024, cash reserves at Fukuda Denshi Co Ltd fell by 7.74bn. However, the company earned 23.91bn from its operations for a Cash Flow Margin of 17.04%. In addition the company used 14.78bn on investing activities and also paid 17.07bn in financing cash flows.
Cash flow per share667.18
Price/Cash flow per share14.28
Book value per share5,965.54
Tangible book value per share5,904.14
More ▼

Balance sheet in JPYView more

Fukuda Denshi Co Ltd has little financial risk as the capital structure does not rely on leverage.
Current ratio4.15
Quick ratio3.59
Total debt/total equity0.0105
Total debt/total capital0.0104
More ▼

Growth rates in JPY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 9.09% and 8.96%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)1.87%
Div growth rate (5 year)15.85%
Payout ratio (TTM)18.40%
EPS growth(5 years)14.62
EPS (TTM) vs
TTM 1 year ago
-9.75
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.